Research
Antitumor activity and immune-related gene expression changes following recombinant Mycobacterium smegmatis treatment in a mouse model of bladder cancer
Nature ·
The Brief
- A study reports antitumour activity of recombinant Mycobacterium smegmatis in a mouse model of bladder cancer.
- The paper also examines changes in immune-related gene expression following treatment.
- The source material provided contains only the title and feed listing, so further details of methods and results are not available here.
Why it matters
It is a preclinical mouse study, so it shows a possible route for bladder cancer immunotherapy that would still need further testing before any clinical relevance is established.
Who’s affected
- bladder cancer researchers
- immunotherapy and cancer biology researchers
- #bladder cancer
- #mycobacterium smegmatis
- #antitumour immunity
- #mouse model
- #immunotherapy